{"transactions":[{"id":2671494,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-11T21:00:44.000Z","date":"2020-08-21","kind":"grant","acquired":true,"shares":1743,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on April 1, 2021 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Employee Stock Option is held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":1743,"derivative":{"exercise_price":5.83,"expiration_date":"2030-08-20","underlying":"Common Stock","underlying_shares":1743},"source":{"system":"sec-edgar","filing":"0001209191-21-039902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121039902/doc4.xml","form_type":"4"}},{"id":2675258,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2021-06-09T22:37:16.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":763,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which each represent a contingent right to receive one share of the Company's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Employee Stock Option is held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":763,"derivative":{"underlying":"Common Stock","underlying_shares":763},"source":{"system":"sec-edgar","filing":"0001209191-21-039278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121039278/doc4.xml","form_type":"4"}},{"id":2675257,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-09T22:37:16.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":1312,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve equal installments at the end of each three-month period over the 36 months following such date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Employee Stock Option is held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":1312,"derivative":{"exercise_price":11.34,"expiration_date":"2031-06-06","underlying":"Common Stock","underlying_shares":1312},"source":{"system":"sec-edgar","filing":"0001209191-21-039278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121039278/doc4.xml","form_type":"4"}},{"id":2712003,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-14T20:50:27.000Z","date":"2021-05-13","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-032773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121032773/doc4.xml","form_type":"4"}},{"id":2712002,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-14T20:50:27.000Z","date":"2021-05-13","kind":"sale","acquired":false,"shares":9675,"price":8.96,"value":86688.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.96 to $9.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2013597,"source":{"system":"sec-edgar","filing":"0001209191-21-032773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121032773/doc4.xml","form_type":"4"}},{"id":2712001,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-14T20:50:27.000Z","date":"2021-05-13","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":2023272,"source":{"system":"sec-edgar","filing":"0001209191-21-032773","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121032773/doc4.xml","form_type":"4"}},{"id":2718238,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-11T20:27:14.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":21514,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-031670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121031670/doc4.xml","form_type":"4"}},{"id":2718237,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-11T20:27:14.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":43028,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-031670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121031670/doc4.xml","form_type":"4"}},{"id":2718236,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-11T20:27:14.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":9746,"price":8.25,"value":80404.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.31. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2001758,"source":{"system":"sec-edgar","filing":"0001209191-21-031670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121031670/doc4.xml","form_type":"4"}},{"id":2718235,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-11T20:27:14.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":2011504,"source":{"system":"sec-edgar","filing":"0001209191-21-031670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121031670/doc4.xml","form_type":"4"}},{"id":2718234,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-11T20:27:14.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":9742,"price":8.57,"value":83488.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1989990,"source":{"system":"sec-edgar","filing":"0001209191-21-031670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121031670/doc4.xml","form_type":"4"}},{"id":2718233,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-11T20:27:14.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1999732,"source":{"system":"sec-edgar","filing":"0001209191-21-031670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121031670/doc4.xml","form_type":"4"}},{"id":2740678,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-23T20:06:12.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":13422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.18,"expiration_date":"2027-03-23","underlying":"Common Stock","underlying_shares":13422},"source":{"system":"sec-edgar","filing":"0001209191-21-028105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121028105/doc4.xml","form_type":"4"}},{"id":2740677,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-23T20:06:12.000Z","date":"2021-04-21","kind":"exercise","acquired":true,"shares":13422,"price":1.18,"value":15837.96,"ownership":{"direct":true},"balance_after":1978218,"source":{"system":"sec-edgar","filing":"0001209191-21-028105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121028105/doc4.xml","form_type":"4"}},{"id":2749381,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-14T20:37:47.000Z","date":"2021-04-12","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":64542,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-026663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026663/doc4.xml","form_type":"4"}},{"id":2749380,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-14T20:37:47.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":9741,"price":8.67,"value":84454.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1964796,"source":{"system":"sec-edgar","filing":"0001209191-21-026663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026663/doc4.xml","form_type":"4"}},{"id":2749379,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-14T20:37:47.000Z","date":"2021-04-12","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1974537,"source":{"system":"sec-edgar","filing":"0001209191-21-026663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026663/doc4.xml","form_type":"4"}},{"id":2751114,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-12T21:06:37.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":86056,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-026375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026375/doc4.xml","form_type":"4"}},{"id":2751113,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-04-12T21:06:37.000Z","date":"2021-04-08","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":107570,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-026375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026375/doc4.xml","form_type":"4"}},{"id":2751112,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-12T21:06:37.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":9737,"price":8.87,"value":86367.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1953023,"source":{"system":"sec-edgar","filing":"0001209191-21-026375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026375/doc4.xml","form_type":"4"}},{"id":2751111,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-12T21:06:37.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1962760,"source":{"system":"sec-edgar","filing":"0001209191-21-026375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026375/doc4.xml","form_type":"4"}},{"id":2751110,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-12T21:06:37.000Z","date":"2021-04-08","kind":"sale","acquired":false,"shares":9736,"price":9,"value":87624.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1941246,"source":{"system":"sec-edgar","filing":"0001209191-21-026375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026375/doc4.xml","form_type":"4"}},{"id":2751109,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-12T21:06:37.000Z","date":"2021-04-08","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1950982,"source":{"system":"sec-edgar","filing":"0001209191-21-026375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121026375/doc4.xml","form_type":"4"}},{"id":2785695,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-16T20:34:40.000Z","date":"2021-03-12","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":129084,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-020823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020823/doc4.xml","form_type":"4"}},{"id":2785694,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:34:40.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":9712,"price":11.36,"value":110328.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.36 to $11.38. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1929468,"source":{"system":"sec-edgar","filing":"0001209191-21-020823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020823/doc4.xml","form_type":"4"}},{"id":2785693,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-16T20:34:40.000Z","date":"2021-03-12","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1939180,"source":{"system":"sec-edgar","filing":"0001209191-21-020823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020823/doc4.xml","form_type":"4"}},{"id":2791396,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-12T23:03:33.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":150598,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-020273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020273/doc4.xml","form_type":"4"}},{"id":2791395,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-12T23:03:33.000Z","date":"2021-03-10","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":172112,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-020273","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020273/doc4.xml","form_type":"4"}},{"id":2791394,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-12T23:03:33.000Z","date":"2021-03-11","kind":"sale","acquired":false,"shares":9711,"price":11.38,"value":110511.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1917666,"source":{"system":"sec-edgar","filing":"0001209191-21-020273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020273/doc4.xml","form_type":"4"}},{"id":2791393,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-12T23:03:33.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1927377,"source":{"system":"sec-edgar","filing":"0001209191-21-020273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020273/doc4.xml","form_type":"4"}},{"id":2791392,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-12T23:03:33.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":9710,"price":11.79,"value":114480.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.61 to $11.80. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1905863,"source":{"system":"sec-edgar","filing":"0001209191-21-020273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020273/doc4.xml","form_type":"4"}},{"id":2791391,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-12T23:03:33.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,613 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on February 22, 2021."}],"balance_after":1915573,"source":{"system":"sec-edgar","filing":"0001209191-21-020273","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121020273/doc4.xml","form_type":"4"}},{"id":2842830,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-22T21:45:29.000Z","date":"2021-02-18","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":193626,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-012745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121012745/doc4.xml","form_type":"4"}},{"id":2842829,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-22T21:45:29.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":9705,"price":12.23,"value":118692.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1889446,"source":{"system":"sec-edgar","filing":"0001209191-21-012745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121012745/doc4.xml","form_type":"4"}},{"id":2842828,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-22T21:45:29.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1899151,"source":{"system":"sec-edgar","filing":"0001209191-21-012745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121012745/doc4.xml","form_type":"4"}},{"id":2849170,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-18T21:44:22.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":215140,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-011888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121011888/doc4.xml","form_type":"4"}},{"id":2849169,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-18T21:44:22.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":236654,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-011888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121011888/doc4.xml","form_type":"4"}},{"id":2849168,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:22.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":9705,"price":12.28,"value":119177.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1877637,"source":{"system":"sec-edgar","filing":"0001209191-21-011888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121011888/doc4.xml","form_type":"4"}},{"id":2849167,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:22.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1887342,"source":{"system":"sec-edgar","filing":"0001209191-21-011888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121011888/doc4.xml","form_type":"4"}},{"id":2849166,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:22.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":9697,"price":13.3,"value":128970.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."}],"balance_after":1865828,"source":{"system":"sec-edgar","filing":"0001209191-21-011888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121011888/doc4.xml","form_type":"4"}},{"id":2849165,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:22.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1875525,"source":{"system":"sec-edgar","filing":"0001209191-21-011888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121011888/doc4.xml","form_type":"4"}},{"id":2891925,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-28T21:00:07.000Z","date":"2021-01-26","kind":"exercise","acquired":false,"shares":21515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":258168,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21515},"source":{"system":"sec-edgar","filing":"0001209191-21-005870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005870/doc4.xml","form_type":"4"}},{"id":2891924,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-28T21:00:07.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":9697,"price":13.37,"value":129648.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.33 to $13.47. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1854011,"source":{"system":"sec-edgar","filing":"0001209191-21-005870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005870/doc4.xml","form_type":"4"}},{"id":2891923,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-28T21:00:07.000Z","date":"2021-01-26","kind":"exercise","acquired":true,"shares":21515,"price":0.04,"value":860.6,"ownership":{"direct":true},"balance_after":1863708,"source":{"system":"sec-edgar","filing":"0001209191-21-005870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005870/doc4.xml","form_type":"4"}},{"id":2894897,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-26T21:56:19.000Z","date":"2021-01-25","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is fully vested and exercisable."}],"balance_after":279683,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-005395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005395/doc4.xml","form_type":"4"}},{"id":2894896,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-26T21:56:19.000Z","date":"2021-01-22","kind":"exercise","acquired":false,"shares":21514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is fully vested and exercisable."}],"balance_after":301197,"derivative":{"exercise_price":0.04,"expiration_date":"2021-05-17","underlying":"Common Stock","underlying_shares":21514},"source":{"system":"sec-edgar","filing":"0001209191-21-005395","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005395/doc4.xml","form_type":"4"}},{"id":2894895,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-26T21:56:19.000Z","date":"2021-01-25","kind":"sale","acquired":false,"shares":9695,"price":13.74,"value":133209.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise for an option grant expiring 05/17/2021, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.70 to $13.86. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1842193,"source":{"system":"sec-edgar","filing":"0001209191-21-005395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005395/doc4.xml","form_type":"4"}},{"id":2894894,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-26T21:56:19.000Z","date":"2021-01-25","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"balance_after":1851888,"source":{"system":"sec-edgar","filing":"0001209191-21-005395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005395/doc4.xml","form_type":"4"}},{"id":2894893,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-26T21:56:19.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":10218,"price":13.53,"value":138249.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise for an option grant expiring 05/17/2021, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.60. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1830374,"source":{"system":"sec-edgar","filing":"0001209191-21-005395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005395/doc4.xml","form_type":"4"}},{"id":2894892,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-26T21:56:19.000Z","date":"2021-01-22","kind":"exercise","acquired":true,"shares":21514,"price":0.04,"value":860.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,651 additional shares acquired under the Company's 2019 Employee Stock Purchase Plan since the reporting person's ownership report filed on September 25, 2019."}],"balance_after":1840592,"source":{"system":"sec-edgar","filing":"0001209191-21-005395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919121005395/doc4.xml","form_type":"4"}},{"id":3114411,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-10T21:00:52.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":202391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares on April 1, 2021 and vests in equal installments at the end of each successive three-month period over the 36 months following such date."}],"balance_after":202391,"derivative":{"exercise_price":8.21,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":202391},"source":{"system":"sec-edgar","filing":"0001209191-20-035591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919120035591/doc4.xml","form_type":"4"}},{"id":3406196,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-25T20:23:45.000Z","date":"2019-09-23","kind":"grant","acquired":true,"shares":262252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date."}],"balance_after":262252,"derivative":{"exercise_price":9.46,"expiration_date":"2029-09-22","underlying":"Common Stock","underlying_shares":262252},"source":{"system":"sec-edgar","filing":"0001209191-19-050699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919119050699/doc4.xml","form_type":"4"}},{"id":3406195,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-25T20:23:45.000Z","date":"2019-09-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 25% of the underlying shares on March 24, 2018 and vests in equal installments at the end of each successive three-month period over the 36 months following such date."}],"balance_after":13422,"derivative":{"exercise_price":1.18,"expiration_date":"2027-03-23","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-050699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919119050699/doc4.xml","form_type":"4"}},{"id":3406194,"issuer":{"id":6284,"kind":"organization","name":"PRECISION BIOSCIENCES INC","symbol":"DTIL"},"owners":[{"id":138351,"kind":"person","name":"KANE MATTHEW R.","position":1,"cik":"0001769887","reported_name":"KANE MATTHEW R.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-25T20:23:45.000Z","date":"2019-09-23","kind":"exercise","acquired":true,"shares":10000,"price":1.18,"value":11800.0,"ownership":{"direct":true},"balance_after":1812427,"source":{"system":"sec-edgar","filing":"0001209191-19-050699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357874/000120919119050699/doc4.xml","form_type":"4"}}]}